Mechanism of Action
- Inhibits water reabsorption in the nephron by blocking the Na-K-Cl cotransporter (NKCC2) in the thick ascending limb of the loop of Henle
Indications
- Pulmonary oedema due to left ventricular failure; thiazide-resistant oedema in patients with chronic heart failure; patients with treatment refractory hypertension (or in patients with poor renal function)
Cautions
- Hypovolaemic/hypotensive patients- ideally correct prior to treatment
- Monitor electrolytes during treatment
- Caution in diabetes (may worsen diabetes- though less commonly than thiazides); same with gout
- In patients with enlarged prostates, loop diuretics may cause urinary retention (make sure an adequate urine outflow before treatment)
Contraindications
- Severe hypokalaemia/hyponatraemia; anuria;
- Severe liver disease causing coma/precoma (may precipitate encephalopathy)
- Renal failure due to neprho-/hepatotoxic drugs
Side effects
- In high IV doses, can cause tinnitus and deafness
- GI disturbance, pancreatitis, hepatic encephalopathy
- Postural hypotension
- Temporary increase in cholesterol/triglycerides
- Electrolyte/metabolic disturbance
- Hyperglycaemia (less common than thiazides)
- Hyponatraemia; hypokalaemia; hypocalcaemia; hypochloraemia; hypomagesaemia
- Metabolic alkalosis
- Hyperuricaemia (gout)
- Rarely, blood disorders e.g. bone marrow suppression, thrombocytopenia, leucopenia